ADAM10 and B-cell chronic lymphocytic leukemia: The non-significant CD58 expression in untreated CLL cases, similar to our findings with ADAM10 mRNA, suggests a potentially distinct regulatory landscape for CD58 in CLL compared to ALL (32).